1. Endothelial Dec1-PPARγ Axis Impairs Proliferation and Apoptosis Homeostasis Under Hypoxia in Pulmonary Arterial Hypertension
    Xiaoming Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  2. Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis
    Xinhui Hu et al, 2024, Renal Failure CrossRef
  3. Targeting PPARs for therapy of atherosclerosis: A review
    Miao Miao et al, 2023, International Journal of Biological Macromolecules CrossRef
  4. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension
    Yang-Zhi-Ge He et al, 2023, Vascular Pharmacology CrossRef
  5. FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
    Meibin Wang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
  6. Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity
    Yingnan Liang et al, 2024, Frontiers in Immunology CrossRef
  7. Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation
    Xiu-chun Li et al, 2024, Acta Pharmacologica Sinica CrossRef
  8. Adipokines in pulmonary hypertension: angels or demons?
    Qi Jia et al, 2023, Heliyon CrossRef
  9. Critical miRNAs in regulating pulmonary hypertension: A focus on Signaling pathways and therapeutic Targets
    Di Wang et al, 2023, Analytical Biochemistry CrossRef
  10. FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway
    Ruixue Li et al, 2024, Cell Biochemistry and Biophysics CrossRef
  11. Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory
    Yunfei Jiang et al, 2022, Heart & Lung CrossRef
  12. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy
    Wei-Jie Xu et al, 2023, Frontiers in Immunology CrossRef
  13. Activating transcription factor 4 aggravates angiotensin II-induced cell dysfunction in human vascular aortic smooth muscle cells via transcriptionally activating fibroblast growth factor 21
    Ke Tao et al, 2022, The Korean Journal of Physiology & Pharmacology CrossRef
  14. Sesamol promotes browning of white adipocytes through liver-adipose crosstalk signal of hepatic fibroblast growth factor 21
    Ming-Hui Cheng et al, 2023, The Journal of Nutritional Biochemistry CrossRef
  15. FGF21 at physiological concentrations regulates vascular endothelial cell function through multiple pathways
    Ni Yang et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  16. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development
    Jaydev Dave et al, 2023, Journal of Translational Medicine CrossRef